Microbial natural products in drug discovery

138Citations
Citations of this article
431Readers
Mendeley users who have this article in their library.

Abstract

Over a long period of time, humans have explored many natural resources looking for remedies of various ailments. Traditional medicines have played an intrinsic role in human life for thousands of years, with people depending on medicinal plants and their products as dietary supplements as well as using them therapeutically for treatment of chronic disorders, such as cancer, malaria, diabetes, arthritis, inflammation, and liver and cardiac disorders. However, plant resources are not sucient for treatment of recently emerging diseases. In addition, the seasonal availability and other political factors put constrains on some rare plant species. The actual breakthrough in drug discovery came concurrently with the discovery of penicillin from Penicillium notatum in 1929. This discovery dramatically changed the research of natural products and positioned microbial natural products as one of the most important clues in drug discovery due to availability, variability, great biodiversity, unique structures, and the bioactivities produced. The number of commercially available therapeutically active compounds from microbial sources to date exceeds those discovered from other sources. In this review, we introduce a short history of microbial drug discovery as well as certain features and recent research approaches, specifying the microbial origin, their featured molecules, and the diversity of the producing species. Moreover, we discuss some bioactivities as well as new approaches and trends in research in this field.

References Powered by Scopus

Natural products as sources of new drugs over the 30 years from 1981 to 2010

4061Citations
N/AReaders
Get full text

Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of Pacific yew

1625Citations
N/AReaders
Get full text

Cyanobacteria secondary metabolites—the cyanotoxins

1301Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Natural products: A lead for drug discovery and development

213Citations
N/AReaders
Get full text

Streptomyces: The biofactory of secondary metabolites

163Citations
N/AReaders
Get full text

Fungal endophytes as efficient sources of plant-derived bioactive compounds and their prospective applications in natural product drug discovery: Insights, avenues, and challenges

116Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Abdel-Razek, A. S., El-Naggar, M. E., Allam, A., Morsy, O. M., & Othman, S. I. (2020, April 1). Microbial natural products in drug discovery. Processes. MDPI AG. https://doi.org/10.3390/PR8040470

Readers over time

‘20‘21‘22‘23‘24‘250306090120

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 100

60%

Researcher 38

23%

Lecturer / Post doc 15

9%

Professor / Associate Prof. 13

8%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 51

33%

Chemistry 40

26%

Agricultural and Biological Sciences 35

22%

Pharmacology, Toxicology and Pharmaceut... 30

19%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 88

Save time finding and organizing research with Mendeley

Sign up for free
0